Clinical Trial Update: A Phase 1b Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of JNJ-64565111 in Participants With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A Phase 1b trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of JNJ-64565111 in adults with type 2 diabetes mellit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• JNJ-64565111

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED